Industry litigation – Page 20
-
Business
Mis-selling lands J&J with $2.2bn fine
Company found guilty of promoting three drugs for unapproved uses
-
Business
Pharma manufacturing woes dog industry
Regulators are stepping up inspections, and discovering ever more problems
-
News
Another drug suspension overturned in India
Safety concerns put sales of antidepressant Deanxit on ice until firms petitioned a high court
-
Business
Lundbeck appeals European antitrust fine
Danish pharmaceutical claims €93.8 million pay-for-delay penalty was the result of ‘serious legal and factual errors’
-
Business
Syngenta takes legal action over pesticide ban
Company claims that the European commission’s two-year moratorium on neonicotinoids to protect bees was wrong
-
Business
Couple charged in GSK corruption investigation
Two private investigators have been charged with breaching the privacy rights of Chinese citizens
-
Business
Obama mandate calls for safer chemical facilities
Agencies need to work together more effectively to improve safety
-
Business
Antiviral patents released by Roche
Firm will supply cheap drugs and allow generics in developing countries
-
Business
India revokes more pharma patents
Original molecule patent stands, but a new salt form is ‘not innovative’
-
Business
Lilly freezes pay as patent cliff looms
Drugmaker targets $400 million savings as two key patents near expiry
-
Business
GSK under investigation over corruption in China
Police claim executives engaged in bribery and tax-related crimes
-
Business
Texas plant explosion prompts calls for stricter rules
The incident was caused by unregulated and improper storage of ammonium nitrate, investigators find
-
Business
Biosimilar drugs step up complexity
First generic monoclonal antibodies recommended for approval in Europe
-
Business
Ups and downs for erectile dysfunction drugs
First new drug in a decade approved in Europe as Viagra patent expires
-
Business
NHS to offer breast cancer prevention drugs
Five-year course of tamoxifen or raloxifene recommended for high risk women
-
Business
Companies urged to publish hidden clinical trial data
Researchers could acquire data and publish themselves if firms refuse
-
Business
GSK fires Chinese R&D head in data investigation
Company is retracting a 2010 study in which data were ‘misrepresented’
-
Business
Pfizer and Takeda win $2.15bn in patent payout
Teva and Sun fined for selling generics before patent expiry